NCT04780256 Endoscopic Resection of Gastrointestinal Neoplasms
| NCT ID | NCT04780256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda USL Reggio Emilia - IRCCS |
| Condition | Endoscopic Mucosal Resection |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2021-03-15 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2021-03-15 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to retrospectively investigate the endoscopic resection procedures of cancerous and precancerous lesions of the upper and lower digestive tract in order to evaluate the efficacy and safety outcomes and to compare different resection techniques. In particular, the resection techniques investigated will be mucosectomy, en bloc and piecemeal, endoscopic submucosal dissection (ESD) and its variants, full-thickness resection. The anatomical districts involved will be the esophagus, stomach, duodenum, colon and rectum.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * all patients who have undergone endoscopic resection of an upper or lower digestive tract tumor Exclusion Criteria: * age under 18 * inability to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04780256 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Endoscopic Mucosal Resection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04780256 currently recruiting?
Yes, NCT04780256 is actively recruiting participants. Contact the research team at paolo.cecinato@ausl.re.it for enrollment information.
Where is the NCT04780256 trial being conducted?
This trial is being conducted at Reggio Emilia, Italy.
Who is sponsoring the NCT04780256 clinical trial?
NCT04780256 is sponsored by Azienda USL Reggio Emilia - IRCCS. The trial plans to enroll 2,000 participants.